tailieunhanh - Respiratory tract infections – antibiotic prescribing

First and foremost, I would like to thank my principal supervisor Dr. Ernest Lam for his support and supervision in carrying out this project. His knowledge, direction and input throughout this project were invaluable. Importantly, I would like to thank and acknowledge Dr. Shimon Friedman for giving me the opportunity to be part of the Graduate Endodontic program at the University of Toronto. The endless hours he contributed along with his knowledge, guidance and support were truly appreciated. It is an honor to call him my mentor. I would also like to thank Dr. Jerry Chapnik who served as. | NHS National Institute for Health and Clinical Excellence Issue date July 2008 Respiratory tract infections - antibiotic prescribing Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care NICE clinical guideline 69 Developed by the Centre for Clinical Practice at NICE Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care Ordering information You can download the following documents from CG069 The full guideline this document - all the recommendations details of how they were developed and reviews of the evidence they were based on A quick reference guide - a summary of the recommendations for healthcare professionals. Understanding NICE guidance - information for patients and carers. For printed copies of the quick reference guide or Understanding NICE guidance phone NICE publications on 0845 003 7783 or email publications@ and quote N1623 quick reference guide N1624 Understanding NICE guidance . NICE clinical guidelines are recommendations about the treatment and care of people with specific diseases and conditions in the NHS in England and Wales This guidance represents the view of the Institute which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient in consultation with the patient and or guardian or carer and informed by the summary of product characteristics of any drugs they are considering. Implementation of this guidance is the responsibility of local commissioners and or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance in their local context in light of .